- AeroCopilot
- /
- Diretivas de Aeronavegabilidade
- /
- 2023-08041
2023-08041
Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs
Resumo Rápido
- Número AD
- 2023-08041
- Autoridade
- FAA
- Data de emissão
- 02/05/2023
- Data efetiva
- 01/06/2023
- Criticidade
- routine
Autoridade
Federal Aviation Administration (EUA)
Data de Publicação
02 de maio de 2023
Data Efetiva
01 de junho de 2023
Prazo de Cumprimento
Antes do próximo voo
Resumo da Diretiva
Esta norma final emenda o programa de teste de drogas da indústria regulada do Departamento de Transportes dos EUA para incluir testes com fluido oral. Esta metodologia adicional de teste de drogas oferecerá aos empregadores uma opção que ajudará a combater fraudes em testes de urina e proporcionará um meio menos intrusivo para alcançar os objetivos de segurança do programa. Para que um empregador implemente testes com fluido oral sob a regulamentação do Departamento, o Departamento de Saúde e Serviços Humanos dos EUA precisará certificar pelo menos dois laboratórios para testes com fluido oral, o que ainda não foi realizado. A norma final inclui outras disposições para atualizar a regulamentação do Departamento e harmonizar, conforme necessário, com as Diretrizes Obrigatórias para Programas Federais de Teste de Drogas no Ambiente de Trabalho Utilizando Fluido Oral estabelecidas pelo Departamento de Saúde e Serviços Humanos dos EUA. Além disso, esta norma emenda as regulamentações da FAA, FMCSA, FRA e FTA para assegurar consistência dentro do Departamento de Transportes e removendo ou ajustando referências à palavra "urina" e/ou adicionando referências a fluido oral, bem como removendo ou emendando algumas definições para conformidade e fazendo outras alterações técnicas ou correções diversas.
This final rule amends the U.S. Department of Transportation's regulated industry drug testing program to include oral fluid testing. This additional methodology for drug testing will give employers a choice that will help combat employee cheating on urine drug tests and provide a less intrusive means of achieving the safety goals of the program. In order for an employer to implement oral fluid testing under the Department's regulation, the U.S. Department of Health and Human Services will need to certify at least two laboratories for oral fluid testing, which has not yet been done. The final rule includes other provisions to update the Department's regulation and to harmonize, as needed, with the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid established by the U.S. Department of Health and Human Services. In addition, this rule amends the FAA, FMCSA, FRA and FTA regulations to ensure consistency within the Department of Transportation and by removing or adjusting references to the word "urine" and/or add references to oral fluid, as well as removing or amending some definitions for conformity and to make other miscellaneous technical changes or corrections.Texto Completo da Diretiva
Expandir texto completo (Federal Register)Texto completo (Federal Register)
Document Headings Document headings vary by document type but may contain the following: • the agency or agencies that issued and signed a document • the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to • the agency docket number / agency internal file number • the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Transportation Federal Aviation Administration Office of the Secretary Federal Railroad Administration Federal Motor Carrier Safety Administration Federal Transit Administration • 14 CFR Part 120 • 49 CFR Part 40 • 49 CFR Parts 219, 240, and 242 • 49 CFR Part 382 • 49 CFR Part 655 • [Docket DOT-OST-2021-0093] • RIN 2105-AE94 ( printed page 27596) AGENCY: Office of the Secretary of Transportation (OST), Federal Aviation Administration (FAA), Federal Motor Carrier Safety Administration (FMCSA), Federal Railroad Administration (FRA), and Federal Transit Administration (FTA); U.S. Department of Transportation (DOT). ACTION: Final rule. SUMMARY: This final rule amends the U.S. Department of Transportation's regulated industry drug testing program to include oral fluid testing. This additional methodology for drug testing will give employers a choice that will help combat employee cheating on urine drug tests and provide a less intrusive means of achieving the safety goals of the program. In order for an employer to implement oral fluid testing under the Department's regulation, the U.S. Department of Health and Human Services will need to certify at least two laboratories for oral fluid testing, which has not yet been done. The final rule includes other provisions to update the Department's regulation and to harmonize, as needed, with the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid established by the U.S. Department of Health and Human Services. In addition, this rule amends the FAA, FMCSA, FRA and FTA regulations to ensure consistency within the Department of Transportation and by removing or adjusting references to the word “urine” and/or add references to oral fluid, as well as removing or amending some definitions for conformity and to make other miscellaneous technical changes or corrections. DATES: This final rule is effective on June 1, 2023. FOR FURTHER INFORMATION CONTACT: For OST, Patrice M. Kelly, JD, Office of Drug and Alcohol Policy and Compliance, 1200 New Jersey Avenue SE, Washington, DC 20590; telephone number 202-366-3784; ODAPCwebmail@dot.gov. For FAA, Nancy Rodriguez-Brown, Deputy Director, Office of Aerospace Medicine, Drug Abatement Division, AAM-800, FAA, 800 Independence Avenue SW, Washington, DC 20591 (telephone: 202-267-8442; drugabatement@faa.gov). For FMCSA, Bryan Price, Chief, Drug and Alcohol Programs Division, Office of Safety Programs, FMCSA, 1200 New Jersey Avenue SE, Washington, DC 20590-0001 (telephone: 202-366-2995; email: bryan.price@dot.gov). For FRA, Gerald Powers, Drug and Alcohol Program Manager, Office of Railroad Safety—Office of Program Management, FRA RRS-25, 1200 New Jersey Avenue SE, Washington, DC 20590-0001 (telephone: 202-493-6313; email: gerald.powers@dot.gov). For FTA, Iyon Rosario, Senior Drug and Alcohol Program Manager, Office of Transit Safety and Oversight (TSO), FTA, 1200 New Jersey Avenue SE, Washington, DC 20590-0001 (telephone: 202-366-2010; email: iyon.rosario@dot.gov). SUPPLEMENTARY INFORMATION: I. Authority for This Rulemaking This rulemaking is promulgated under the authority originally enacted in the Omnibus Transportation Employee Testing Act (OTETA) of 1991, codified at 49 U.S.C. 45102 and 45104 (aviation indust…
Fonte: Federal Register (federalregister.gov). Texto original em inglês. Conteúdo sanitizado por segurança.
Documentos e Referências
Monitore DAs automaticamente para sua aeronave
Cadastre sua aeronave no AeroCopilot e receba alertas por e-mail e notificação quando novas diretivas de aeronavegabilidade afetarem seu tipo de aeronave.
Dados obtidos do Federal Register (federalregister.gov). As informações são fornecidas para fins de consulta — consulte sempre a fonte oficial para fins de compliance regulatório.